Bill · H.R. 5630· House(119-HR-5630)
To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.
- Introduced
- 9/30/2025
- Last activity
- 9/30/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Erin Houchin
- Cosponsors
- None
- Introduced
- In Committee
What this bill would do
This bill proposes an amendment to the Public Health Service Act. It specifically targets State plans regarding Substance Use Prevention, Treatment, and Recovery Services block grants. The legislation would require states to include additional specific information in these plans. This information must cover drug types used for medication-assisted treatment and the protocols used to prevent diversion and misuse. Additionally, states would need to report data on the misuse of such drugs and their specific drug screening protocols.
Yes· 3 of 5
Does this do more about addiction and overdose deaths?+4
The bill requires reporting on drug misuse and diversion prevention protocols to better manage medication-assisted treatment within the public health landscape.
Does this make what the government does easier for the public to see?+3
The bill increases transparency regarding state-level drug treatment options and the protocols used to prevent drug misuse.
Does this make mental health care easier to get?+2
The bill enhances oversight of medication-assisted treatment which is a critical component of mental health and substance use recovery.
The opposite
Does this leave more decisions to the states?-2
The bill reduces state autonomy by imposing more specific reporting requirements on how state substance use block grants are planned and managed.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Transparency of Treatment Options: States would be required to describe the types of drugs available for medication-sisted treatment within their care system, providing clarity on available resources. (Section 1, clause xi, I)
-
Focus on Safety and Prevention: The bill requires states to outline programs or protocols used specifically for the prevention and enforcement of drug diversion and misuse. (Section 1, clause xi, II)
-
Enhanced Data Collection on Drug Misuse: By requiring data on instances where medication-assisted treatment is mixed with other prescription drugs, the bill seeks to track potential misuse. (Section 1, clause xi, III)
-
Standardization of Screening Procedures: The requirement for states to report data on drug screening protocols, including those for patients receiving medication-assisted treatment, provides oversight of these systems. (Section 1, clause xi, IV)
Potential Negative Impacts for People
- No negative impacts are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Opioid Crisis Response+4Improves Mental Health Access+2
- Demographic And Interest Groups
- Good For Low Income Households+2Good For Urban Residents+1
- Governance And Ideology
- Improves Government Transparency+3Increase States Rights-2
- 9/30/2025
- Referred to the House Committee on Energy and Commerce.
- Introduced in House